Xuanchu C. Duan

139 Renmin Middle Road
Changsha, 410011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Tafluprost/timolol fixed-dose combination versus tafluprost monotherapy for open-angle glaucoma and ocular hypertension: a multicenter, randomized, double-blind, parallel-group trial

Tafluprost/timolol fixed-dose combination versus tafluprost monotherapy for open-angle glaucoma and ocular hypertension: a multicenter, randomized, double-blind, parallel-group trial

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: September 07, 2026

Deconstructing Anterior Segment Crowding: Preoperative Anatomical Predictors of Malignant Glaucoma After Primary Angle-Closure Glaucoma Surgery.

Deconstructing Anterior Segment Crowding: Preoperative Anatomical Predictors of Malignant Glaucoma After Primary Angle-Closure Glaucoma Surgery.

Journal: Journal of visualized experiments : JoVE

Published: August 18, 2026

Genome Wide Pleiotropic Analysis Reveals Shared Genetic Architecture and Pathological Basis Between Retinitis Pigmentosa and Relevant Ocular Comorbidities.

Genome Wide Pleiotropic Analysis Reveals Shared Genetic Architecture and Pathological Basis Between Retinitis Pigmentosa and Relevant Ocular Comorbidities.

Journal: Seminars in ophthalmology

Published: June 26, 2026

Differential Effects of EP3, FP, and EP2 Receptor Agonists on Orbital Adipogenesis in a 3D Spheroid Model of Thyroid Eye Disease.

Differential Effects of EP3, FP, and EP2 Receptor Agonists on Orbital Adipogenesis in a 3D Spheroid Model of Thyroid Eye Disease.

Journal: Current eye research

Published: February 16, 2026

The Role of Viral Infection and Microbial Dysbiosis in Glaucoma: From Pathogenesis to Therapeutic Strategies.

The Role of Viral Infection and Microbial Dysbiosis in Glaucoma: From Pathogenesis to Therapeutic Strategies.

Journal: Viruses

Published: January 28, 2026

Digoxin Attenuates Ocular Hypertension and Protects Trabecular Meshwork Cells via Ferroptosis Inhibition.

Digoxin Attenuates Ocular Hypertension and Protects Trabecular Meshwork Cells via Ferroptosis Inhibition.

Journal: Investigative ophthalmology & visual science

Published: January 21, 2026

Knowledge, attitude and practice towards glaucoma among ophthalmic inpatients: a cross-sectional study in Hunan, China.

Knowledge, attitude and practice towards glaucoma among ophthalmic inpatients: a cross-sectional study in Hunan, China.

Journal: BMJ open

Published: January 16, 2026

Hydrogels as Promising Carriers for Ophthalmic Disease Treatment: A Comprehensive Review.

Hydrogels as Promising Carriers for Ophthalmic Disease Treatment: A Comprehensive Review.

Journal: Gels (Basel, Switzerland)

Published: December 28, 2025

Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma: Two-year Results of a Prospective Multicenter Study.

Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma: Two-year Results of a Prospective Multicenter Study.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: November 13, 2025

Clinical application prospects and challenges of preservative-free anti-glaucoma drugs

Clinical application prospects and challenges of preservative-free anti-glaucoma drugs

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: September 08, 2025

Identification of a chromatin regulator signature and potential candidate drugs for primary open-angle glaucoma.

Identification of a chromatin regulator signature and potential candidate drugs for primary open-angle glaucoma.

Journal: Epigenomics

Published: March 17, 2025

Targeting mitochondrial dysfunction: Innovative strategies to combat glaucoma neuroinflammation.

Targeting mitochondrial dysfunction: Innovative strategies to combat glaucoma neuroinflammation.

Journal: Experimental eye research

Published: March 10, 2025

Showing 1-12 of 80

Last Updated: 09/26/2026